Where does the human data stop and the extrapolation begin? That is the whole thread.

Half of what people describe as tolerance is a change in the underlying condition, and the two need different answers.

The cheapest option costs more once you price in the failure rate. Eight months in on a redelivery and it lines up.

Imprint databases are mostly US-centric. A confident hit for another market is still a guess.

It gets smaller. Not easy, smaller. That distinction kept me going.

You have two changes at once here. You cannot attribute anything until one of them moves.

Reference ranges differ between labs, so comparing two reports is close to meaningless.

Imprint databases are mostly US-centric. A confident hit for another market is still a guess.

Worth asking what specifically was measured. Pain scores move with mood and function does not. Same for me with a slow cooker, unfortunately.